All posts by: Michael Zand

Emerging Trends And Dynamics In The Cancer Immunotherapy Market Through 2016 – 2024 – Medgadget (blog)

Symposium discusses latest and future of stem cell therapy – The Pasadena Star-News

The Pasadena Star-NewsSymposium discusses latest and future of stem cell therapyThe Pasadena Star-NewsIn the Phase I clinical trial, the patient, who did not respond to other types of therapy including radiation and even developed tumors in his brain a… Continue reading

Stem cells help some men with erectile dysfunction after prostate surgery – The Guardian

NBCNews.comStem cells help some men with erectile dysfunction after prostate surgeryThe GuardianMen unable to have an erection after prostate surgery enjoyed normal intercourse thanks to stem cell therapy, scientists are to report on Saturday at a medi… Continue reading

Stem Cells Show Mixed Results for Impotence After Prostate Surgery – NBCNews.com

NBCNews.comStem Cells Show Mixed Results for Impotence After Prostate SurgeryNBCNews.comDanish researchers trying to find a way to help men badly injured by prostate cancer surgery say they got mixed results with an experimental new approach: injecting… Continue reading

Study shows potential of stem cell therapy to repair lung damage – Medical Xpress

Study shows potential of stem cell therapy to repair lung damageMedical XpressA new study has found that stem cell therapy can reduce lung inflammation in an animal model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Although, st… Continue reading

Immunotherapy drug becomes first therapy approved by FDA for … – Medical Xpress

Medical XpressImmunotherapy drug becomes first therapy approved by FDA for …Medical XpressThe U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with&amp… Continue reading